The Gilead deal couldn’t have been timed better to help activate M&A activity and continue to spur a biotech bull market. It is however a reminder that Mega-Mergers are still a distant memory.
from Forbes Real Time //www.forbes.com/sites/stephenbrozak/2017/08/30/gilead-kite-a-new-transformative-deal-and-maybe-the-new-future-of-healthcare-deals/
via IFTTT
No comments:
Post a Comment